Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kiniksa Pharmaceuticals (KNSA)
NASDAQ:KNSA
Kiniksa Pharmaceuticals (KNSA) Financial Statements
362 Followers
Kiniksa Pharmaceuticals Financial Overview
| Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 54.49M | $ 48.34M | $ 61.88M | $ 99.14M | $ 26.97M |
| Gross Profit | $ 63.77M | $ 41.31M | $ 47.65M | $ 87.58M | $ 21.94M |
| EBIT | $ -1.24M | $ -9.36M | $ 7.30M | $ 46.41M | $ -19.37M |
| EBITDA | $ -1.79M | $ -9.83M | $ 7.70M | $ 46.91M | $ -18.72M |
| Net Income Common Stockholders | $ 14.97M | $ -12.27M | $ 4.46M | $ 224.09M | $ -19.98M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 184.99M | $ 187.49M | $ 190.61M | $ 200.72M | $ 138.21M |
| Total Assets | $ 484.33M | $ 442.86M | $ 459.67M | $ 459.95M | $ 210.58M |
| Total Debt | $ 13.52M | $ 5.62M | $ 5.92M | $ 6.71M | $ 4.61M |
| Net Debt | $ -171.47M | $ -181.88M | $ -184.69M | $ -194.01M | $ -133.59M |
| Total Liabilities | $ 72.68M | $ 52.77M | $ 459.66M | $ 75.94M | $ 57.08M |
| Stockholders Equity | $ 411.65M | $ 390.10M | $ 396.14M | $ 384.01M | $ 153.49M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -3.78M | $ -4.29M | $ -11.53M | $ 62.03M | $ -7.94M |
| Operating Cash Flow | $ -3.74M | $ -4.27M | $ -11.58M | $ 62.05M | $ -7.82M |
| Investing Cash Flow | $ 35.53M | $ -37.92M | $ -42.66M | $ 19.04M | $ 38.27M |
| Financing Cash Flow | $ 158.00K | $ 90.00K | $ 1.19M | $ 361.00K | $ 542.00K |